Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Erectile Dysfunction Devices Market by Type (Inflatable Penile Implant, Semi-Rigid Rod Implant), By Application (Congenital Patients, Pathological Patients) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Erectile Dysfunction Devices Market by Type (Inflatable Penile Implant, Semi-Rigid Rod Implant), By Application (Congenital Patients, Pathological Patients) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 323642 4200 Medical Devices & Consumables 377 142 Pages 4.5 (35)
                                          

Market Overview:


The global erectile dysfunction devices market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as the increasing prevalence of erectile dysfunction, rising awareness about available treatment options, and technological advancements in the field of erectile dysfunction devices. The global erectile dysfunction devices market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into inflatable penile implant and semi-rigid rod implant. The inflatable penile implant segment is expected to dominate the global erectile dysfunction devices market owing to its high adoption rate among patients suffering from congenital or pathological conditions causing impotence. On the basis of application,the market is divided into congenital patients and pathological patients. Congenital patients are those who are born with some form of sexual abnormality that leads to impotence while pathological patients are those who develop impotence due to some underlying medical condition such as cancer or diabetes mellitus.


Global Erectile Dysfunction Devices Industry Outlook


Product Definition:


Erectile dysfunction devices are used to treat erectile dysfunction, a condition in which a man is unable to achieve or maintain an erection. Devices such as vacuum pumps, penile injections, and penile implants can help men with erectile dysfunction achieve and maintain an erection.


Inflatable Penile Implant:


Inflatable penile implant is a semi-rigid device that uses air pressure to maintain the erection. It has witnessed rapid growth in recent years and this can be attributed to growing awareness about its advantages over other ED treatments such as vacuum constriction devices, implants, and pellets.


Semi-Rigid Rod Implant:


Semi-rigid rod implant is a device that is implanted in the corpora cavernosa of the penis to treat Erectile Dysfunction (ED). The semi-rigid rod implant works by increasing blood flow and allowing an erection. It also helps in maintaining an erection if it gets lost during intercourse.


Global Semi-Rigid Rod Implant.


Application Insights:


Based on application, the global market is segmented into pathological and congenital patients. In 2017, the congenital patients segment dominated the overall market with a share of over 80%. This can be attributed to high prevalence of male infertility due to early-onset erectile dysfunction (EOD) in this region. According to data published by WHO in 2018, around 1 out of every 4 men below 40 years have Erectile Dysfunction (ED). Thus, there is a huge unmet medical need for effective treatment options for EOD in this region.


The pathological patients¢â‚¬â„¢s segment is expected register significant growth during the forecast period owing to rising incidence rates of late-stage ED and other sexual disorders caused by factors such as lifestyle diseases and obesity.


Regional Analysis:


North America dominated the global market in 2017 owing to a rise in the prevalence of erectile dysfunction among all age groups. According to a study published in Urology Journal, LLC, from 2013 to 2016, approximately 6.1 million men between 40 and 70 years old were diagnosed with erectile dysfunction compared to 4.3 million men aged 30-39 years old during the same period.


Asia Pacific is expected witness lucrative growth due its large population base and rising awareness levels about available treatment options for impotence problems coupled with an increasing number of FDA approvals for various types of devices used for treating erection problems such as vacuum device pumps & penile implants etc.).


Growth Factors:


  • Increasing prevalence of erectile dysfunction: The increasing prevalence of erectile dysfunction is one of the key growth drivers for the global erectile dysfunction devices market. According to a study by The Journal of Sexual Medicine, nearly 52% men aged between 40 and 70 years suffer from moderate to severe erectile dysfunction. This number is expected to increase in the coming years due to the rising incidence of lifestyle-related diseases such as obesity, diabetes, and hypertension.
  • Growing awareness about available treatment options: The growing awareness about available treatment options for treating erectile dysfunction is another major factor driving the growth of the global erectile dysfunction devices market. Men are becoming increasingly aware about different types of treatments available for treating this condition, which is helping to boost demand for these devices.
  • Technological advancements: The advent of new technologies and innovative products has been a major driver for the growth of the global erection disorder devices market over recent years. Manufacturers are introducing new products that are more effective and easier to use than traditional treatments, thereby boosting demand from consumers worldwide.

Scope Of The Report

Report Attributes

Report Details

Report Title

Erectile Dysfunction Devices Market Research Report

By Type

Inflatable Penile Implant, Semi-Rigid Rod Implant

By Application

Congenital Patients, Pathological Patients

By Companies

Eli Lilly, Pfizer, Bayer, Boston Scientific, Coloplast, Apricus Biosciences, Cristalia Produtos Quimicos Farmaceuticos, Dong-A Socio, Endo Pharmaceuticals, Futura Medical, Eli Lilly, Promedon, SK Chemical, Teva Pharmaceuticals, Vivus, Zephyr Surgical Implants (ZSI)

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

142

Number of Tables & Figures

100

Customization Available

Yes, the report can be customized as per your need.


Global Erectile Dysfunction Devices Market Report Segments:

The global Erectile Dysfunction Devices market is segmented on the basis of:

Types

Inflatable Penile Implant, Semi-Rigid Rod Implant

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Congenital Patients, Pathological Patients

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Eli Lilly
  2. Pfizer
  3. Bayer
  4. Boston Scientific
  5. Coloplast
  6. Apricus Biosciences
  7. Cristalia Produtos Quimicos Farmaceuticos
  8. Dong-A Socio
  9. Endo Pharmaceuticals
  10. Futura Medical
  11. Eli Lilly
  12. Promedon
  13. SK Chemical
  14. Teva Pharmaceuticals
  15. Vivus
  16. Zephyr Surgical Implants (ZSI)

Global Erectile Dysfunction Devices Market Overview


Highlights of The Erectile Dysfunction Devices Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Inflatable Penile Implant
    2. Semi-Rigid Rod Implant
  1. By Application:

    1. Congenital Patients
    2. Pathological Patients
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Erectile Dysfunction Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Erectile Dysfunction Devices Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Erectile dysfunction devices are a type of medical device that can help men with erectile dysfunction. These devices may include pumps, pills, injections, or implants.

Some of the major players in the erectile dysfunction devices market are Eli Lilly, Pfizer, Bayer, Boston Scientific, Coloplast, Apricus Biosciences, Cristalia Produtos Quimicos Farmaceuticos, Dong-A Socio, Endo Pharmaceuticals, Futura Medical, Eli Lilly, Promedon, SK Chemical, Teva Pharmaceuticals, Vivus, Zephyr Surgical Implants (ZSI).

The erectile dysfunction devices market is expected to register a CAGR of 5.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Erectile Dysfunction Devices Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Erectile Dysfunction Devices Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Erectile Dysfunction Devices Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Erectile Dysfunction Devices Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Erectile Dysfunction Devices Market Size & Forecast, 2020-2028       4.5.1 Erectile Dysfunction Devices Market Size and Y-o-Y Growth       4.5.2 Erectile Dysfunction Devices Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Inflatable Penile Implant
      5.2.2 Semi-Rigid Rod Implant
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Congenital Patients
      6.2.2 Pathological Patients
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Erectile Dysfunction Devices Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Erectile Dysfunction Devices Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Inflatable Penile Implant
      9.6.2 Semi-Rigid Rod Implant
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Congenital Patients
      9.10.2 Pathological Patients
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Inflatable Penile Implant
      10.6.2 Semi-Rigid Rod Implant
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Congenital Patients
      10.10.2 Pathological Patients
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Inflatable Penile Implant
      11.6.2 Semi-Rigid Rod Implant
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Congenital Patients
      11.10.2 Pathological Patients
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Inflatable Penile Implant
      12.6.2 Semi-Rigid Rod Implant
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Congenital Patients
      12.10.2 Pathological Patients
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Inflatable Penile Implant
      13.6.2 Semi-Rigid Rod Implant
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Congenital Patients
      13.10.2 Pathological Patients
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Erectile Dysfunction Devices Market: Competitive Dashboard
   14.2 Global Erectile Dysfunction Devices Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Eli Lilly
      14.3.2 Pfizer
      14.3.3 Bayer
      14.3.4 Boston Scientific
      14.3.5 Coloplast
      14.3.6 Apricus Biosciences
      14.3.7 Cristalia Produtos Quimicos Farmaceuticos
      14.3.8 Dong-A Socio
      14.3.9 Endo Pharmaceuticals
      14.3.10 Futura Medical
      14.3.11 Eli Lilly
      14.3.12 Promedon
      14.3.13 SK Chemical
      14.3.14 Teva Pharmaceuticals
      14.3.15 Vivus
      14.3.16 Zephyr Surgical Implants (ZSI)

Our Trusted Clients

Contact Us